TNTatiana G. Nonka

Tatiana G. Nonka

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Tatiana G. Nonka has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Elena V. Lebedeva

    Cardiology Research Institute, Tomsk National Research Medical Center (NRMC), Russian Academy of Sciences; Mental Health Research Institute, Tomsk National Research Medical Center (NRMC), Russian Academy of Sciences

    9 shared publications
  • Aleksey N. Repin

    Cardiology Research Institute, branch of the Federal State Budgetary Scientific Institution “Tomsk National Research Medical Center of the Russian Academy of Sciences

    8 shared publications
  • Evgeniy D. Schastnyy

    Department of Affective States, Mental Health Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk 634014, Russia

    5 shared publications
  • Svetlana N. Vasilieva

    Department of Affective States, Mental Health Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk 634014, Russia

    3 shared publications
  • A. N. Repin

    Cardiology Research Institute, Tomsk National Research Medical Center (NRMC), Russian Academy of Sciences

    2 shared publications
  • German G. Simutkin

    Mental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk 634014, Russia

    2 shared publications

Latest Publications

  • Open Access

    INSOMNIA AND DISORDERS IN HEART RATE VARIABILITY IN PATIENTS WITH CORONARY HEART DISEASE AND DEPRESSIVE DISORDERS

    by Татьяна Геннадьевна Нонка, Елена Владимировна Лебедева, Алексей Николаевич Репин

    HighlightsPatients with coronary heart disease often present with comorbid depressive disorders, insomnia and a significant decrease in heart rate variability, which can aggravate the clinical course of the disease and increase the risk of sudden death. AbstractAim. To study the presence and severity of insomnia and the range of heart rate variability (HRV), as well as their relationship in a patient with coronary heart disease (CHD) with depressive disorders (DD).Methods. The study included 101 patients with CHD (more than 6 months after myocardial infarction): 67 patients with DD and 34 patients without DD. The Beck Depression Scale consultations with a psychotherapist were used to diagnose DD. Sleep disturbances were assessed using the Sheehan Rating Scale. HRV parameters were assessed using the SCHILLER MT-200 Holter-ECG device. Data are presented as M ± SD; n (%); Me [25%; 75%], tables of connectivity and χ2 criteria were used. The difference was considered significant at p Results. Sleep disturbances and night awakenings in the general group of patients occurred in the following cases: none or clinically not significant – 50 (49.5%) cases, clinically significant – 51 (50.5%) cases. Sleep disturbances and night awakenings were significantly pronounced in CHD patients with DD compared with patients without DD: clinically significant sleep disturbances in 45 vs 6 patients (p = 0.00001), night awakenings – 43 vs 8 patients (p = 0.003), respectively. In patients with DD, compared to patients without DD, a significant decrease in HRV was noted in the following parameters: SDNN (97 [83; 113] ms vs 110 [98; 124] ms, p = 0.01), SDANN 80 [67; 94] ms vs 91 [79; 102] ms, p = 0.01), SDNN index (46 [38; 56] ms vs 55 [48; 66] ms, p = 0.005), pNN50% (4 [2.4; 5.7] vs 6 [ 3; 12.6], p = 0.02). There was a more significant decrease in the SDNN index in patients with severe sleep disturbances, compared with patients with normal sleep (38 [34; 51] ms vs 57 [48; 61] ms, p = 0.02).Conclusion. Changes in the circadian rhythm in CHD patients with DD take the form of insomnia and a significant decrease in HRV. Insomnia increases sympathetic activation, which aggravates the clinical course of CHD and increases the risk of sudden death due to arrhythmias.

  • Open Access

    Sleep disturbances in patients with comorbid coronary heart disease and depression

    by T. G. Nonka, E. V. Lebedeva, A. N. Repin, E. D. Schastnyy

    Aim. To study the presence and severity of insomnia in patients with comorbid coronary heart disease (CHD) and depressive disorder (DD).Materials and methods. The study included 132 patients with CHD (class II–III exertional angina after myocardial infarction experienced more than 6 months ago): 58 patients with DD and 74 patients without depression. The Beck Depression Inventory (BDI) was used to diagnose DD. The diagnosis in all cases was confirmed by a therapist. Sleep disturbances were assessed using the Sheehan Patient-Rated Anxiety Scale (ShAS). The data were presented as M ± SD; n (%); and Me [25%; 75%]. The differences were considered significant at p < 0.05.Results. Insomnia in the general group of patients was registered as follows: none or clinically not significant – in 62 patients (54.9%), clinically significant – in 51 patients (45.1%). Night awakenings in the general group of patients were detected as follows: none or clinically not significant – in 66 patients (58.4%), clinically significant – in 47 patients (41.6%). Disturbances in falling asleep and night awakenings were significantly pronounced in patients with CHD with identified DD compared to patients without mental disorders: disturbances in falling asleep – 2 [1; 3] vs. 1 [0; 2] (p = 0.0001), night awakenings – 2 [1; 3] vs. 1 [0; 2] (p = 0.00002), respectively. In the group of CHD with DD (n = 58), 2 people (3.4%) did not complete the scale. Among those who did, 12 patients (21.4%) had no difficulty falling asleep, 9 patients (16.1%) had little difficulty, and 35 patients (62.5%) had clinically significant disturbances. In the group of CHD without DD (n = 74), 17 people (23%) did not complete the scale. Among those who did (n = 57), 21 patients (36.8%) had no difficulty falling asleep, 20 patients (35.1%) had little difficulty, and 16 patients (28.1%) had clinically significant problems. In patients with comorbid CHD and DD who completed the ShARS (n = 56), 7 patients (12.5%) had no night awakenings, 17 patients (30.4%) had few night awakenings, and 32 patients (57.1%) had clinically significant disturbances in maintaining sleep. In the group without DD, among those who completed the ShARS (n = 57), 18 patients (31.6%) had no night awakenings, 24 patients (42.1%) had few night awakenings, and 15 patients (26.4%) had clinically significant disturbances in maintaining sleep. Significant differences were noted for all test questions (p < 0.0005).Conclusion. In patients with comorbid CHD and DD, changes in the circadian rhythm are detected in the form of significant disturbances in falling asleep and awakening, which can aggravate the clinical course of CHD and the prognosis of patients with cardiovascular diseases.

  • Open Access

    Clinical and dynamic features of bipolar affective disorder in patients with chronic coronary artery disease

    by E. V. Lebedeva, E. D. Schastnyy, G. G. Simutkin, T. G. Nonka, S. N. Vasilieva, A. N. Repin

    Introduction. Currently, the study of comorbidity, which is characteristic of the clinical picture of modern patients, is relevant. This also applies to psychiatric disorders in cardiovascular diseases, which are common, affect social functioning and determine the clinical and biological characteristics of patients and prognosis. Bipolar disorder and coronary heart disease are one example of such a comorbidity. Recent evidence suggests that up to 40% of patients with bipolar disorder die from cardiovascular disease.Aim: To study the frequency of bipolar disorders and their clinical and dynamic features in patients with chronic coronary artery disease with the assessment of seven-year survival rates.Material and Methods. Patients with confirmed chronic coronary artery disease, aged 35–70 years, living in Tomsk and the Tomsk Region: the main group (with identified mood disorders, diagnosed by a psychiatrist, n = 262) and the comparison group (without mood or other mental disorders, n = 291). The Hamilton Depression Scale for Seasonal Affective Disorders was used to assess depressive symptoms. The survival tables and Kaplan – Meier methods were used to assess survival, survival curves were compared using the Mantel – Cox logrank test.Results. The frequency of bipolar disorder among hospitalized patients with chronic coronary artery disease was three times higher than that in the population. Depressive symptoms in bipolar disorder did not differ clinically from those in other mood disorders. The prognostic signs indicating the risk of bipolar disorder include: family history with mental disorders, atypical specification of depression, earlier age of onset of depression, high multimorbidity with mental (anxiety disorders, dependence syndrome due to alcohol, nicotine) and physical diseases. According to a retrospective assessment, coronary artery disease in half of the cases developed against the background of bipolar disorder. During the 7-year follow-up period, the number of cases of bipolar disorder doubled compared to the beginning of the study. Patients with bipolar disorder had more frequent acute myocardial infarction and had clinically more significant functional classes of angina pectoris and heart failure.Conclusion. During the 7-year follow-up period, the number of patients with bipolar disorder doubled. Patients with this comorbidity had an unfavorable prognosis in terms of survival (62.5%) compared with individuals without mood disorders.

  • Open Access

    Clinical features of coronary artery disease and 5-year survival of patients after myocardial infarction against the background of depressive disorders

    by Tatiana G. Nonka, Elena V. Lebedeva, Alexey N. Repin

    Aim. To assess the features of the clinical picture of coronary artery disease (CAD) and the prognosis of patients with myocardial infarction with depressive disorder (DD). Materials and methods. We examined 101 patients with stable CAD who had myocardial infarction more than six months ago: 67 CAD patients with depression (Group 1) and 34 CAD patients without depression (Group 2). The clinical picture of CAD was assessed by complaints, angina self-monitoring diaries, and exercise tests. The presence and severity of DD was determined using psychometric scales: BDI (Beck Depression Scale), HADS (Hospital Anxiety and Depression Scale) and the opinion of a psychiatrist. Five-year survival information was obtained through telephone interviews with patients and their relatives. Results. In patients with CAD and DD in comparison with patients without DD self-monitoring diaries revealed more frequent angina attacks: 9 [6; 12] vs 6 [4; 7] per week (p=0.0001), the greater need for sublingual nitrates: 2 [0; 9] pills vs 0 [0; 4] pills (p=0.0001). DD significantly reduced exercise tolerance: 370 [250; 450] meters vs 435 [350; 500] meters using the six-minute walk test (p=0.04), according to the results of bicycle ergometry – 50 [25; 75] W vs 75 [50; 75] W (p=0.03). After 5 years of follow-up patients with comorbidities (CAD and DD) had a greater number of deaths: 13 (19.4%) vs 2 (5.9%), respectively, survived – 54 (80.6%) vs 32 (94.1%) (Gehan–Wilcoxon test, p=0.04). Conclusion. The comorbidity CAD and DD leads to a worsening of the clinical course of CAD and prognosis, which actualizes the need for verification of the diagnosis of DD and timely prescription of antidepressant therapy.


  • Open Access

    The effect of depressive disorder on the clinical presentation of coronary artery disease and five-year survival of patients after myocardial infarction

    by T. G. Nonka, E. V. Lebedeva, A. N. Repin

    Aim. To assess the effect of depressive disorder (DD) on the clinical presentation of coronary artery disease (CAD) and five-year survival rate of patients with chronic CAD.Materials and methods. The study included 79 patients with functional class II–III exertional angina who experienced myocardial infarction more than 6 months before. The patients were divided into two groups: group 1 (n = 45) consisted of patients with CAD and depression and group 2 (n = 34) encompassed patients with CAD without depression. The clinical presentation of CAD was assessed by the results of filling out the angina pectoris self-control diary and exertion tests. The presence and severity of DD were determined using psychometric scales, such as Hospital Anxiety and Depression Scale (HADS) and Beck Depression Inventory (BDI), and verified by the psychiatrist. Information about five-year survival was obtained via telephone interviews with the patients and their relatives.Results. Patients with CAD and DD were characterized by more frequent episodes of angina pectoris during a week (10 [8; 14] vs 6 [4; 7], p = 0.000004), an increased demand for nitroglycerin (4 [0; 10] tablets vs 0 [0; 4] tablets, p = 0.001), and lower exercise tolerance (50 [25; 75] W vs 75 [50; 75] W (p = 0.06), 350 [250; 400] meters vs 435 [350; 500] meters (p = 0.01) than CAD patients without DD. The five-year survival rate was significantly lower in group 1 than in group 2 (69 [62; 72] vs 71 [68; 72] months (p = 0.04)), 35 (77.8%) vs 32 (94.1%) patients survived. In group 1, a greater number of deaths from cardiovascular accidents (10 (22.2%) vs 2 (5.9%)) was noted (log-rank test, p = 0.03).Conclusion. In patients with CAD, associated depression results in aggravation of the clinical course of CAD and poor disease prognosis, which requires timely diagnosis and treatment of DD.


  • Open Access

    The impact of affective disorders on self-assessment of the quality of life in patients with chronic coronary artery disease

    by E. V. Lebedeva, E. D. Schastnyу, T. G. Nonka, E. O. Nalesnik, A. K. Surovtseva, S. N. Vasilieva, A. N. Repin

    Aim. To determine the differences in self-assessment of social functioning by patients with chronic coronary artery disease (CAD), depending on the presence of comorbid affective disorders (ADs).Materials and methods. Using the Social Adaptation Self-Evaluation Scale (SASS), which makes it possible to assess the degree of social functioning and satisfaction with various aspects of social life, we studied the features of the social functioning of heart hospital patients with chronic CAD with (n = 248) and without AD (n = 291). In 290 patients (average age 56.6 ± 6.7 years) with chronic CAD, chronic ADs (45%) were revealed; depressive episodes (DEs) were diagnosed for the first time in 24% of patients, and 24.5% of patients had recurrent DEs. Bipolar disorder was found in 6.5% of cases. Qualitative and quantitative parameters were investigated using the Mann – Whitney U test and Student’s t-test. To assess the frequencies, the Pearson’s chi-squared test was used.Results. The mean total SASS score in the patients with chronic CAD with AD corresponded to difficult social adaptation (33.7 [29.5; 39]), while the patients without AD had good social adaptation score of 40.8 ± 6.3 (p < 0.05). In the group without AD, patients with normal social adaptation prevailed (n = 215; 73.8%), while patients with AD more often had difficulties with social adaptation (n = 148; 59.7%). In the CAD patients, depending on the presence of AD, the frequency of disturbances in various spheres of social adaptation differed: employment, interest in and pleasure from activities, disposition of income, pleasure from and interest in seeking information, social support (p = 0.001).Conclusion. Higher frequency of pronounced impairment in social functioning in patients with chronic CAD with AD determines the need for taking this fact into consideration when planning rehabilitation measures in this group of patients.

  • Open Access

    Possibilities of detecting and correcting decreased heart rate variability in patients with coronary artery disease in combination with depressive disorders in a cardiology department

    by T. G. Nonka, E. V. Lebedeva, A. N. Repin

    Возможности выявления и коррекции сниженной вариабельности ритма сердца у больных ишемической болезнью сердца в сочетании с депрессиями в условиях кардиологического отделения


  • Open Access

    Gender differences in self-reported social functioning of patients with chronic coronary artery disease and affective disorders

    by E. V. Lebedeva, E. D. Schastnyy, T. G. Nonka, A. N. Repin

    Гендерные различия самооценки социального функционирования пациентов с хронической ИБС и аффективными расстройствами


  • Open Access

    Effects of agomelatine on heart rate variability in patients with coronary artery disease and depression

    by T. G. Nonka, E. V. Lebedeva, A. N. Repin

    Aim. To determine heart rate variability (HRV) in depressed patients with chronic coronary artery disease (CAD) and to assess the effects of agomelatine on HRV.Methods. 74 patients with CAD (class 3-4 angina pectoris) were recruited in a study. Patients (n = 45) with CAD and depression were assigned to Group 1, whereas CAD patients (n = 29) without any signs of depression were assigned to Group 2. 17 patients received agomelatine (Subgroup 1) and 28 patients did not take any antidepressants (Subgroup 2). HRV was measured using SCHILLER MT-200 Holter-ECG apparatus at baseline and after 6 months.Results. Patients with depression demonstrated a significant decrease in HRV compared to non-depressed patients (pNN50% (3.9 [2.2; 5.4] vs 5.7 [2.9; 12.6], p = 0.03), SDANN (81 [63; 97] ms vs 91 [79; 102] ms, p = 0.06), SDNNindx (46 [36; 56] ms vs 55 [48; 66] ms, p = 0.002), rMSSD (28 [21; 36] ms vs 33 [ 29; 45] ms, p = 0.02), SDNN (97 [75; 121] ms vs 110 [98; 127] ms, p = 0.02). Subgroups 1 and 2 did not differ in HRV (p>0.05). After 6 months, significant differences in the following parameters were found in those patients who received agomelatine therapy and those who did not: rMSSD (36.5 [28.5; 51] ms vs 26.5 [25; 32] ms, p = 0.02), SDANN (88 [72,5; 114,5] ms vs 67,5 [58; 83] ms, p = 0.03), SDNN strives to a significant difference - 100 [87; 133.5] ms vs 85.5 [75; 103] ms, p = 0.07.Conclusion. HRV significantly decreased in depressed patients with CAD suggesting autonomic dysfunction and worsening their prognosis. Agomelatine therapy in patients with CAD is effective in treating heart rate variability and reducing the risk of developing life-threatening arrhythmias.Key


  • ATYPICAL DEPRESSION IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE

    by E.V. Lebedeva, E.D. Schastny, G.G. Simutkin, T.G. Nonka, S.N. Vasil'Eva, A.N. Repin